Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Diffuse cutaneous mastocytosis (DCM) is a rare form of cutaneous mastocytosis (CM) characterized by generalized erythroderma, various degrees of blistering, skin with a ''peau d'orange'' appearance and the accumulation of mast cells in the skin. At least two DCM variants are recognized, one with extreme blistering (Bullous DCM) and one with infiltrations (Pseudoxanthomatous DCM).
Features include very common findings: Pruritus, Generalized abnormality of skin, Darier's sign, and Flushing and others; and common findings: Urticaria, Thickened skin, Vomiting, and Diarrhea and others. 31 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 9 | Pruritus, Generalized abnormality of skin, Urticaria |
Phenotype severity distribution: 5 very common features, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for diffuse cutaneous mastocytosis.
9 publications have been identified in PubMed for diffuse cutaneous mastocytosis. Research spans Review / Meta-Analysis (44%), Case Report / Case Series (44%), and Basic Science / Preclinical (11%).
Carter MC (2026). [PMID: 41285204](https://pubmed.ncbi.nlm.nih.gov/41285204/). *The journal of allergy and clinical immunology. In practice*. [Review / Meta-Analysis]
Kasmi D (2026). [PMID: 41836292](https://pubmed.ncbi.nlm.nih.gov/41836292/). *Frontiers in cell and developmental biology*. [Basic Science / Preclinical]
Giavina-Bianchi M (2026). [PMID: 41958536](https://pubmed.ncbi.nlm.nih.gov/41958536/). *J Allergy Clin Immunol Glob*. [Case Report / Case Series]
Chang J (2025). [PMID: 41060361](https://pubmed.ncbi.nlm.nih.gov/41060361/). *Pediatric dermatology*. [Case Report / Case Series]
Pernea P (2025). [PMID: 40434754](https://pubmed.ncbi.nlm.nih.gov/40434754/). *JAMA dermatology*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:54 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Digestive system
7 |
Spleen abnormalities (abnormality of the spleen), Vomiting, Diarrhea |
Brain and nerves | 2 | Myeloproliferative disorder, Headache |
Bones and joints | 1 | Abnormal bone marrow cell morphology |
Metabolism | 1 | Fever |
Lungs and breathing | 1 | Wheezing |
Moran CA (2025). [PMID: 40543670](https://pubmed.ncbi.nlm.nih.gov/40543670/). *Journal of the American Academy of Dermatology*. [Review / Meta-Analysis]
Mendiratta V (2025). [PMID: 41262266](https://pubmed.ncbi.nlm.nih.gov/41262266/). *Indian journal of dermatology*. [Case Report / Case Series]
Kozmane S (2025). [PMID: 40978899](https://pubmed.ncbi.nlm.nih.gov/40978899/). *Cureus*. [Case Report / Case Series]
Madigan LM (2025). [PMID: 40392511](https://pubmed.ncbi.nlm.nih.gov/40392511/). *American journal of clinical dermatology*. [Review / Meta-Analysis]